FAITH GEBHARDT: Open Payments
NPI 1023575420 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,229 in 47 payments from 13 companies in 2025. Trend: 2023 $5,950 · 2024 $13,152 · 2025 $1,229
Food & beverage: $890Speaker / faculty: $263Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $391 |
| Boston Scientific Corporation | 2 | $263 |
| Lundbeck LLC | 4 | $111 |
| Axsome Therapeutics, Inc. | 5 | $100 |
| Janssen Biotech, Inc. | 2 | $92 |
| UCB, Inc. | 3 | $84 |
| ACADIA Pharmaceuticals Inc | 2 | $51 |
| PFIZER INC. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Averitas Pharma Inc. | 1 | $25 |
Products named: Intracept, QULIPTA, UBRELVY, VYEPTI, Symbravo, Nayzilam, NUPLAZID, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
